Risk and Benefit of Oral Anticoagulants in Atrial Fibrillation

被引：0
|
作者：
Zotova, I. V. [1 ]
Zateyshchikov, D. A. [1 ]
机构：
[1] President RF, FSI Educ Sci Med Ctr, Gen Management Dept, Moscow 121356, Russia
来源：
KARDIOLOGIYA | 2011年 / 51卷 / 10期
关键词：
atrial fibrillation; indirect anticoagulants; thromboembolism; bleeding; risk stratification; CLINICAL CLASSIFICATION SCHEMES; MAJOR BLEEDING COMPLICATIONS; SOLUBLE CD40 LIGAND; WARFARIN THERAPY; STROKE RISK; VENOUS THROMBOEMBOLISM; ARTERIAL EMBOLISM; NATIONAL REGISTRY; PREDICTING STROKE; ISCHEMIC-STROKE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Thromboembolism is the main cause of death and disability of patients with atrial fibrillation. Indirect anticoagulants are effective means of primary and secondary prevention of thromboembolic complications. However in a number of patients risk associated with therapy with indirect anticoagulants might exceed potential benefit. The principle problem requiring solution in a patient with atrial fibrillation is individual comparative assessment of risk of development of thromboembolic and hemorrhagic complications. Modern stratification scales which allow solving this problem are considered in this review.
引用
收藏
页码：81 / 91
页数：11
相关论文
共 50 条
  • [21] Direct Oral Anticoagulants and Mortality in Atrial Fibrillation
    Ellis, Martin
    Ruslan, Sergienko
    Ariel, Hammerman
    Greenberg-Dotan, Sari
    Battat, Erez
    Hamburger-Avnery, Orly
    Greenberg, Dan
    Ronen, Arbel
    BLOOD, 2018, 132
  • [22] Oral anticoagulants for Asian patients with atrial fibrillation
    Sabir, Ian
    Khavandi, Kaivan
    Brownrigg, Jack
    Camm, A. John
    NATURE REVIEWS CARDIOLOGY, 2014, 11 (05) : 290 - 303
  • [23] Oral anticoagulants in older adults with atrial fibrillation
    Gwen M. Bernacki
    Richard C. Becker
    Journal of Thrombosis and Thrombolysis, 2013, 36 : 403 - 415
  • [24] The new oral anticoagulants in atrial fibrillation: an update
    F. W. A. Verheugt
    Netherlands Heart Journal, 2013, 21 : 480 - 484
  • [25] PATTERNS OF ORAL ANTICOAGULANTS USE IN ATRIAL FIBRILLATION
    Brais, C.
    Larochelle, J.
    Turgeon, M. H.
    Tousignant, A. S.
    Blais, L.
    Perreault, S.
    Farand, P.
    Letemplier, G.
    Beauchesne, M. F.
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2015, 22 (01): : E90 - E95
  • [26] New Oral Anticoagulants in Atrial Fibrillation Forever?
    Verheugt, Freek W. A.
    CIRCULATION, 2013, 128 (03) : 200 - 202
  • [27] Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
    Senoo, Keitaro
    Lane, Deirdre A.
    Lip, Gregory Y. H.
    CURRENT PROBLEMS IN CARDIOLOGY, 2014, 39 (09) : 319 - 344
  • [28] New oral anticoagulants in nonvalvular atrial fibrillation
    Lega, Jean-Christophe
    Bertoletti, Laurent
    Durupt, Stephane
    Epinat, Magali
    Mismetti, Patrick
    Da Costa, Antoine
    Laporte, Silvy
    PRESSE MEDICALE, 2013, 42 (09): : 1225 - 1231
  • [29] Oral anticoagulants for Asian patients with atrial fibrillation
    Ian Sabir
    Kaivan Khavandi
    Jack Brownrigg
    A. John Camm
    Nature Reviews Cardiology, 2014, 11 : 290 - 303
  • [30] New oral anticoagulants in atrial fibrillation: are they comparable?
    Kalodiki, E.
    Lewis, B.
    Fareed, J.
    INTERNATIONAL ANGIOLOGY, 2012, 31 (04) : 307 - 309
12345